Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors
Karim Fizazi(Université Paris-Sud), Charles G. Drake(Columbia University Irving Medical Center), Tomasz M. Beer(Oregon Health & Science University), Eugene D. Kwon(Mayo Clinic in Arizona), Howard I. Scher(Memorial Sloan Kettering Cancer Center), Winald R. Gerritsen(Radboud University Nijmegen), Alberto Bossi(Institut Gustave Roussy), Alfons J.M. van den Eertwegh(Amsterdam UMC Location Vrije Universiteit Amsterdam), Michael Krainer(Vienna General Hospital), Nadine Houédé(Université de Montpellier), Ricardo Vieira Santos, Hakim Mahammedi(Centre Jean Perrin), Siobhan Ng(St John of God Subiaco Hospital), Riccardo Danielli(University of Siena), Fábio Franke, Santhanam Sundar(Nottingham University Hospitals NHS Trust), Neeraj Agarwal(University of Utah), Andries M. Bergman(The Netherlands Cancer Institute), Tudor–Eliade Ciuleanu(Institute of Oncology Prof. Dr. Ion Chiricuta), Ernesto Korbenfeld(Hospital Británico de Buenos Aires), Lisa Sengeløv(Herlev Hospital), Steinbjørn Hansen(Odense University Hospital), M. Brent McHenry(Bristol-Myers Squibb (United States)), Allen Chen(Bristol-Myers Squibb (United States)), Christopher J. Logothetis(The University of Texas MD Anderson Cancer Center)
Cited by 174Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis